EcoDrugPlus

G Protein-Coupled Receptor 84

Ensembl ID : ENSUAMG00000021971
Gene Symbol: GPR84
2 Cross references
124 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSUAMG00000023464
Gene Symbol: HCK
2 Cross references
205 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSUAMG00000026022
Gene Symbol: ITK
2 Cross references
207 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSUAMG00000009390
Gene Symbol: JAK1
2 Cross references
236 Possible Orthologues:

Janus Kinase 2

Ensembl ID : ENSUAMG00000005671
Gene Symbol: JAK2
2 Cross references
265 Possible Orthologues:

Janus Kinase 3

Ensembl ID : ENSUAMG00000018350
Gene Symbol: JAK3
2 Cross references
103 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSUAMG00000014061
Gene Symbol: KIT
2 Cross references
265 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSUAMG00000016388
Gene Symbol: KRAS
2 Cross references
203 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSUAMG00000000376
Gene Symbol: MAPKAPK2
2 Cross references
233 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSUAMG00000001704
Gene Symbol: MAPKAPK5
2 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 1

Ensembl ID : ENSUAMG00000003802
Gene Symbol: MKNK1
2 Cross references
167 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSUAMG00000026804
Gene Symbol: MKNK2
2 Cross references
220 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).